Introduction; Intended Use - Medline HEMO-FORCE MDS600INT2 Instrucciones De Operación

INTRODUCTION

The Hemo-Force® is an Intermittent Pneumatic Compression System
that counteracts blood stasis and coagulation changes; two of the three
major factors that promote deep vein thrombosis (DVT) a potentially
life threatening condition which can lead to pulmonary embolism.
The Hemo-Force® is a non-invasive mechanical prophylactic system
that massages the feet or legs in a wavelike, milking motion that
promotes blood flow and deters thrombosis, helping to empty pooled
or static blood from the valve cusps of the femoral vein. Fibrinolytic
activity is increased, stimulating the release of a plasminogen
activator. This therapy typically complements other prophylactic
measures, such as antiembolic stockings and anticoagulants.
Some exciting features include:
• User friendly master control unit that is designed so that its functions
are self-explanatory
• Power button (ON/OFF)
• An alarm displays a fault status with an audio alarm and LCD display
• LCD display that can monitor errors, statuses
and pressure values of the device
• Timer indicator that reflects each hour of compression
• A button (RESET) that causes a counter to take the state
corresponding to a specified initial number (zero)
• Battery indicator that can show remaining battery status
• Unique hanging bracket that provides easy attachment

INTENDED USE

The system consists of an air pump and single-patient-use compression
sleeve – one for the foot, one for the calf and one for the thigh. The air
pump and compression sleeve may be used on one lower extremity. The
inflation pressure settings are pre-set by the manufacturer and cannot be
changed. The compression level for the foot sleeve is 120mmHg (16kPa).
The compression level for the calf and thigh sleeve is 40mmHg. The sleeve
inflates and maintains compression for 12 seconds. Then, the sleeve deflates
for a period of 48 seconds. As the sleeve inflates, it compresses the foot,
calf or thigh which augments venous blood flow, thereby reducing stasis.
This process also stimulates fibrinolysis; thus, reducing the risk of early clot
formation. Regularly check the system while in use, assuring pump operation
and sleeve fit. Please note: The intended user of the system includes children,
adolescents and adult but the system can only be used under the instruction
from the physician no matter in hospital, nursing home or other locations.
3